186 related articles for article (PubMed ID: 28255354)
21. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.
Deng W; Qiu J; Wang S; Yuan Z; Jia Y; Tan H; Lu J; Zheng R
Int J Nanomedicine; 2018; 13():439-453. PubMed ID: 29403275
[TBL] [Abstract][Full Text] [Related]
22. Melanin-loaded biocompatible photosensitive nanoparticles for controlled drug release in combined photothermal-chemotherapy guided by photoacoustic/ultrasound dual-modality imaging.
Wang W; Jing T; Xia X; Tang L; Huang Z; Liu F; Wang Z; Ran H; Li M; Xia J
Biomater Sci; 2019 Oct; 7(10):4060-4074. PubMed ID: 31475710
[TBL] [Abstract][Full Text] [Related]
23. Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.
Ding D; Tang X; Cao X; Wu J; Yuan A; Qiao Q; Pan J; Hu Y
AAPS PharmSciTech; 2014 Feb; 15(1):213-22. PubMed ID: 24287627
[TBL] [Abstract][Full Text] [Related]
24. Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo.
Tang QS; Chen DZ; Xue WQ; Xiang JY; Gong YC; Zhang L; Guo CQ
Int J Nanomedicine; 2011; 6():3077-85. PubMed ID: 22163161
[TBL] [Abstract][Full Text] [Related]
25. Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer.
Tang H; Chen J; Wang L; Li Q; Yang Y; Lv Z; Bao H; Li Y; Luan X; Li Y; Ren Z; Zhou X; Cong D; Liu Z; Jia J; Chen H; Zhao W; Meng Q; Sun F; Pei J
Int J Pharm; 2020 Jan; 573():118806. PubMed ID: 31678519
[TBL] [Abstract][Full Text] [Related]
26. Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers.
Liu L; Bi Y; Zhou M; Chen X; He X; Zhang Y; Sun T; Ruan C; Chen Q; Wang H; Jiang C
ACS Appl Mater Interfaces; 2017 Mar; 9(8):7424-7435. PubMed ID: 28150932
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer.
Cao Q; Li ZB; Chen K; Wu Z; He L; Neamati N; Chen X
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1489-98. PubMed ID: 18373091
[TBL] [Abstract][Full Text] [Related]
28. Co-administration of paclitaxel and 2-methoxyestradiol using folate-conjugated human serum albumin nanoparticles for improving drug resistance and antitumor efficacy.
Liu X; Zhao T; Xu Y; Huo P; Xu X; Zhang Z; Tian Q; Zhang N
Pharm Dev Technol; 2021 Jan; 26(1):1-10. PubMed ID: 32985928
[TBL] [Abstract][Full Text] [Related]
29. The nanoparticle-facilitated autophagy inhibition of cancer stem cells for improved chemotherapeutic effects on glioblastomas.
Lu L; Shen X; Tao B; Lin C; Li K; Luo Z; Cai K
J Mater Chem B; 2019 Mar; 7(12):2054-2062. PubMed ID: 32254809
[TBL] [Abstract][Full Text] [Related]
30. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q
J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854
[TBL] [Abstract][Full Text] [Related]
31. Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment.
Song B; Wu S; Li W; Chen D; Hu H
Pharm Res; 2020 Nov; 37(12):242. PubMed ID: 33188481
[TBL] [Abstract][Full Text] [Related]
32. Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas.
Cheng WT; Ho HO; Lin SY; Liu DZ; Chen LC; Sheu MT
Int J Nanomedicine; 2021; 16():6825-6841. PubMed ID: 34675510
[TBL] [Abstract][Full Text] [Related]
33. Radioluminescent nanoparticles for radiation-controlled release of drugs.
Misra R; Sarkar K; Lee J; Pizzuti VJ; Lee DS; Currie MP; Torregrosa-Allen SE; Long DE; Durm GA; Langer MP; Elzey BD; Won YY
J Control Release; 2019 Jun; 303():237-252. PubMed ID: 31026550
[TBL] [Abstract][Full Text] [Related]
34. Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.
Wang J
Drug Des Devel Ther; 2020; 14():823-832. PubMed ID: 32161442
[TBL] [Abstract][Full Text] [Related]
35. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
36. Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer.
Mohammad IS; Teng C; Chaurasiya B; Yin L; Wu C; He W
Int J Pharm; 2019 Feb; 557():304-313. PubMed ID: 30599232
[TBL] [Abstract][Full Text] [Related]
37. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
[No Abstract] [Full Text] [Related]
38. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
39. Hybrid paclitaxel and gold nanorod-loaded human serum albumin nanoparticles for simultaneous chemotherapeutic and photothermal therapy on 4T1 breast cancer cells.
Peralta DV; Heidari Z; Dash S; Tarr MA
ACS Appl Mater Interfaces; 2015 Apr; 7(13):7101-11. PubMed ID: 25768122
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]